A new diagnostic method could help identify one of the deadliest types of interstitial lung disease (ILD) sooner, allowing for faster treatment and improved patient outcomes.
Jul 26, 2022
0
6
For military personnel who were deployed to Iraq and Afghanistan in the early 2000s, burn pits—areas where various waste was burned in open pits—were a visceral reminder of that hellish experience.
Jun 15, 2022
0
23
Mount Sinai researchers have validated for the first time that a simple blood test called a liquid biopsy could be a better predictor of whether cancer immunotherapy will be successful for a patient with lung cancer than ...
Jun 2, 2022
0
1
UC Davis Health physicians have performed the first single-anesthesia diagnosis to treatment of lung cancer using a fully robotic approach in the UC Health System.
May 17, 2022
0
11
Patients who are at a higher risk of their lung cancer returning can be identified by a personalized blood test that is performed after treatment, according to researchers at the University of Cambridge.
Mar 18, 2022
0
72
For the first time, the high safety and low mortality of a still novel, simpler procedure for lung biopsies has also been shown in a European context. The so-called transbronchial cryobiopsy was performed in 75 patients in ...
Mar 4, 2022
0
21
To diagnose lung cancer, tumor tissue is collected from a patient and checked for signs of cancer. However, this is not always possible due to tumor location, and can be painful for the patient. For his Ph.D. research, Remco ...
Dec 14, 2021
0
1
Non-small cell lung cancer (NSCLC) patients with higher measures of tumor mutations that show up in a blood test generally have a better clinical response to PD-1-based immunotherapy treatments than patients with a lower ...
Feb 26, 2020
0
2
A new method of determining the sequence of molecules in DNA can be used to detect small fragments of cancerous genetic material in blood samples from lung cancer patients with a high degree of accuracy, according to new ...
Mar 19, 2019
0
5
A multi-center study led by researchers at The University of Texas MD Anderson Cancer Center revealed that a liquid biopsy test called Guardant360, is comparable to standard tissue biopsies in detection of guideline recommended ...
Feb 27, 2019
1
3
